Patents by Inventor Stephen Eck

Stephen Eck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11003651
    Abstract: RI/ORASE history and current transaction data are stored in partitioned fact tables and aggregation tables based on business calendar. Most of associated indexes are locally partitioned indexes. In a typical RI customer environment, partitioned transaction data takes 85% or more of overall RI database space. The benefits of partitioning include easy management of data, enhanced performance, and assistance with backup and recovery. A partition management system provides the ability to create initial partitions and manage existing partitions in ways that allow the size of the partitioned database to exceed a backup limit size.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 11, 2021
    Assignee: Oracle International Corporation
    Inventors: Jing Ge, Allen John Violette, Bharath Krishnan Narayanan, Stephen Eck
  • Publication number: 20200167330
    Abstract: RI/ORASE history and current transaction data are stored in partitioned fact tables and aggregation tables based on business calendar. Most of associated indexes are locally partitioned indexes. In a typical RI customer environment, partitioned transaction data takes 85% or more of overall RI database space. The benefits of partitioning include easy management of data, enhanced performance, and assistance with backup and recovery. A partition management system provides the ability to create initial partitions and manage existing partitions in ways that allow the size of the partitioned database to exceed a backup limit size.
    Type: Application
    Filed: November 28, 2018
    Publication date: May 28, 2020
    Inventors: Jing GE, Allen John VIOLETTE, Bharath Krishnan NARAYANAN, Stephen ECK
  • Publication number: 20050222163
    Abstract: The present invention relates to methods for treating cancer comprising utilizing a combination of signal transduction inhibitors. More specifically, the present invention relates to combinations of so called cell cycle inhibitors with mitogen stimulated kinase signal transduction inhibitors, more specifically combinations of CDK inhibitors with mitogen stimulated kinase signal transduction inhibitors, more preferably MEK inhibitors. Other embodiments of the invention relate to additional combinations of the aforesaid combinations with standard anti-cancer agents such as cytotoxic agents, palliatives and antiangiogenics.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 6, 2005
    Inventors: Stephen Eck, David Fry, Judith Leopold